We didn’t wait for the next advance against cancer. We created it.
Learn why our CSO, Nick Keen, is #NotWaiting.
We didn’t wait for the next advance against cancer. We created it.
Learn why our U.K. team is #NotWaiting.
View all news

News

18 March 2019
Bicycle Therapeutics Appoints Pierre Legault as New Director and Board Chairman

Social Media

@Bicycle_tx Mar 21
Bicycle Research Scientist Rachel Dods presents a poster today at the Annual BSAC Spring Conference entitled “PBP i… http://p55lLB7u3r

Our Programs

We are focused on developing three categories of Bicycles against our oncology targets:

Bicycle Toxin ConjugatesBicycle Targeted Innate Immune ActivatorsBicycle T-Cell Modulators

Our Technology

Learn about our revolutionary Bicycle technology

Beyond Oncology

Bicycle programs outside of cancer